Your browser doesn't support javascript.
loading
Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor-Modified T-cell Therapy for CEA+ Liver Metastases.
Katz, Steven C; Burga, Rachel A; McCormack, Elise; Wang, Li Juan; Mooring, Wesley; Point, Gary R; Khare, Pranay D; Thorn, Mitchell; Ma, Qiangzhong; Stainken, Brian F; Assanah, Earle O; Davies, Robin; Espat, N Joseph; Junghans, Richard P.
Afiliación
  • Katz SC; Department of Surgery, Roger Williams Medical Center, Providence, Rhode Island/Boston University School of Medicine, Boston, Massachusetts.
  • Burga RA; Department of Surgery, Roger Williams Medical Center, Providence, Rhode Island/Boston University School of Medicine, Boston, Massachusetts.
  • McCormack E; Department of Medicine, Roger Williams Medical Center, Providence, Rhode Island/Boston University School of Medicine, Boston, Massachusetts.
  • Wang LJ; Department of Pathology, Roger Williams Medical Center, Providence, Rhode Island.
  • Mooring W; Department of Pathology, Roger Williams Medical Center, Providence, Rhode Island.
  • Point GR; Department of Surgery, Roger Williams Medical Center, Providence, Rhode Island/Boston University School of Medicine, Boston, Massachusetts.
  • Khare PD; Roger Williams Medical Center, GMP Core Facility and Clinical Protocol Office, Providence, Rhode Island.
  • Thorn M; Department of Surgery, Roger Williams Medical Center, Providence, Rhode Island/Boston University School of Medicine, Boston, Massachusetts.
  • Ma Q; Department of Medicine, Roger Williams Medical Center, Providence, Rhode Island/Boston University School of Medicine, Boston, Massachusetts.
  • Stainken BF; Department of Radiology, Roger Williams Medical Center, Providence, Rhode Island/Boston University School of Medicine, Boston, Massachusetts.
  • Assanah EO; Department of Radiology, Roger Williams Medical Center, Providence, Rhode Island/Boston University School of Medicine, Boston, Massachusetts.
  • Davies R; Roger Williams Medical Center, GMP Core Facility and Clinical Protocol Office, Providence, Rhode Island.
  • Espat NJ; Department of Surgery, Roger Williams Medical Center, Providence, Rhode Island/Boston University School of Medicine, Boston, Massachusetts.
  • Junghans RP; Department of Medicine, Roger Williams Medical Center, Providence, Rhode Island/Boston University School of Medicine, Boston, Massachusetts. rjunghans@rwmc.org.
Clin Cancer Res ; 21(14): 3149-59, 2015 Jul 15.
Article en En | MEDLINE | ID: mdl-25850950
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_digestive_diseases / 6_liver_cancer Asunto principal: Quimioterapia del Cáncer por Perfusión Regional / Receptores de Antígenos de Linfocitos T / Linfocitos T / Adenocarcinoma / Inmunoterapia / Neoplasias Hepáticas Tipo de estudio: Guideline Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2015 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_digestive_diseases / 6_liver_cancer Asunto principal: Quimioterapia del Cáncer por Perfusión Regional / Receptores de Antígenos de Linfocitos T / Linfocitos T / Adenocarcinoma / Inmunoterapia / Neoplasias Hepáticas Tipo de estudio: Guideline Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2015 Tipo del documento: Article